Liposomal Thiostrepton Formulation and Its Effect on Breast Cancer Growth Inhibition. (2021)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xphs.2021.01.018
PubMed Identifier: 33515584
Publication URI: http://europepmc.org/abstract/MED/33515584
Type: Journal Article/Review
Volume: 110
Parent Publication: Journal of pharmaceutical sciences
Issue: 6
ISSN: 0022-3549